All In Biotech

Drug Trial Radar · NCT07623200

A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

A Phase 3, Randomized, Open-Label Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia and a CALR Mutation Previously Treated With Cytoreductive Therapy (EXCALIBUR-ET2)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 426 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

426

Planned (sponsor's estimate)

Start

Sep 8, 2026

Primary completion

Jun 15, 2029

Study completion Nov 1, 2030

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Jun 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to evaluate INCA033989 versus best available therapy in participants with essential thrombocythemia and a CALR mutation previously treated with cytoreductive therapy.

Conditions

  • Essential Thrombocythemia

Interventions

  • INCA033989Drug

    Administered intravenous (IV) in accordance with the protocol-defined requirements.

  • Best Available TreatmentDrug

    Best Available Therapy (BAT) will be selected by the investigator.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Durable clinicohematologic response (DCR)Time frame: Week 24

Locations

196 sites in 22 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham Comprehensive Cancer Center

    Birmingham, Alabama · Not yet recruiting

  • Banner Md Anderson Cancer Center

    Gilbert, Arizona · Not yet recruiting

  • City of Hope Medical Center

    Duarte, California · Recruiting

  • Marin Cancer Care

    Greenbrae, California · Recruiting

  • University of California, San Diego-Moores Cancer Center

    La Jolla, California · Not yet recruiting

  • University of California, Los Angeles Medical Center

    Los Angeles, California · Not yet recruiting

  • Stanford Cancer Center

    Palo Alto, California · Not yet recruiting

  • Rocky Mountain Cancer Centers-Lone Tree

    Lone Tree, Colorado · Not yet recruiting

  • Medstar Georgetown Medical Center, Inc

    Washington D.C., District of Columbia · Not yet recruiting

  • Florida Cancer Specialists & Research Institute

    Fort Myers, Florida · Not yet recruiting

  • University of Miami Sylvester Comprehensive Cancer Center

    Miami, Florida · Not yet recruiting

  • Cleveland Clinic

    Weston, Florida · Not yet recruiting

  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University

    Chicago, Illinois · Not yet recruiting

  • University of Chicago

    Chicago, Illinois · Not yet recruiting

  • The University of Kansas Cancer Center

    Westwood, Kansas · Not yet recruiting

  • Our Lady of the Lake Medical Center

    Baton Rouge, Louisiana · Not yet recruiting

  • Johns Hopkins Medicine-the Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland · Not yet recruiting

  • Maryland Oncology Hematology, P.A.

    Columbia, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Not yet recruiting

  • Beth Israel Deaconess Medical Center (Bidmc)

    Boston, Massachusetts · Not yet recruiting

  • University of Massachusetts Medical School

    Worcester, Massachusetts · Not yet recruiting

  • University of Michigan Rogel Cancer Center Adult Bone Marrow Transplant Clinic

    Ann Arbor, Michigan · Not yet recruiting

  • Missouri Cancer Associates

    Columbia, Missouri · Not yet recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Not yet recruiting

  • University of Nebraska Medical Center

    Omaha, Nebraska · Not yet recruiting

  • John Theurer Cancer Center, Hackensack University Medical Center

    Hackensack, New Jersey · Not yet recruiting

  • Icahn School of Medicine At Mount Sinai

    New York, New York · Not yet recruiting

  • Memorial Sloan Kettering Cancer Center

    New York, New York · Not yet recruiting

  • Weill Cornell Medical College - Newyork-Presbyterian Hospita

    New York, New York · Not yet recruiting

  • Strong Memorial Hospital University of Rochester Medical Center

    Rochester, New York · Not yet recruiting

  • Duke University Medical Center

    Durham, North Carolina · Not yet recruiting

  • Cleveland Clinic Taussig Cancer Ctr

    Cleveland, Ohio · Not yet recruiting

  • Willamette Valley Cancer Institute and Research Center

    Eugene, Oregon · Recruiting

  • Oregon Health and Science University

    Portland, Oregon · Not yet recruiting

  • Thomas Jefferson University Sidney Kimmel Medical College

    Philadelphia, Pennsylvania · Not yet recruiting

  • Medical University of South Carolina, Hollings Cancer Center

    Charleston, South Carolina · Not yet recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Not yet recruiting

  • Baylor Charles A. Sammons Cancer Center

    Dallas, Texas · Not yet recruiting

  • Baylor St Luke'S Medical Center

    Houston, Texas · Not yet recruiting

  • The University of Texas-Md Anderson Cancer Center

    Houston, Texas · Not yet recruiting

Showing 40 of 196 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.